This report aims to provide a comprehensive presentation of the global market for Post-Polycythemia Vera Myelofibrosis (PPV-MF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Polycythemia Vera Myelofibrosis (PPV-MF). This report contains market size and forecasts of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in global, including the following market information:
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Durvalumab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Post-Polycythemia Vera Myelofibrosis (PPV-MF) include AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, Incyte Corp, Italfarmaco SpA, JW Pharmaceutical Corp and MedImmune LLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Post-Polycythemia Vera Myelofibrosis (PPV-MF) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, by Type, 2022 (%)
Durvalumab
Givinostat
Glasdegib
Idelalisib
IMG-7289
Others
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Celgene Corp
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
Incyte Corp
Italfarmaco SpA
JW Pharmaceutical Corp
MedImmune LLC
MEI Pharma Inc
Merck & Co Inc
Novartis AG
NS Pharma Inc
Promedior Inc
Sun Pharma Advanced Research Company Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Post-Polycythemia Vera Myelofibrosis (PPV-MF), market overview.
Chapter 2: Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market size in revenue.
Chapter 3: Detailed analysis of Post-Polycythemia Vera Myelofibrosis (PPV-MF) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Overall Market Size
2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size: 2022 VS 2032
2.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players in Global Market
3.2 Top Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies Ranked by Revenue
3.3 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Companies
3.4 Top 3 and Top 5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players in Global Market
3.6.1 List of Global Tier 1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies
3.6.2 List of Global Tier 2 and Tier 3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Markets, 2022 & 2032
4.1.2 Durvalumab
4.1.3 Givinostat
4.1.4 Glasdegib
4.1.5 Idelalisib
4.1.6 IMG-7289
4.1.7 Others
4.2 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
4.2.1 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2023
4.2.2 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2024-2032
4.2.3 By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
5.2.1 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2023
5.2.2 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2024-2032
5.2.3 By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2022 & 2032
6.2 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue & Forecasts
6.2.1 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2023
6.2.2 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2024-2032
6.2.3 By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032
6.3.2 US Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.3.3 Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.3.4 Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032
6.4.2 Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.3 France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.4 U.K. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.5 Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.6 Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.7 Nordic Countries Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.4.8 Benelux Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032
6.5.2 China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.5.3 Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.5.4 South Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.5.5 Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.5.6 India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032
6.6.2 Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.6.3 Argentina Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032
6.7.2 Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.7.3 Israel Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.7.4 Saudi Arabia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
6.7.5 UAE Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, 2018-2032
7 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.1.4 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.1.5 AbbVie Inc Key News & Latest Developments
7.2 Celgene Corp
7.2.1 Celgene Corp Company Summary
7.2.2 Celgene Corp Business Overview
7.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.2.4 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.2.5 Celgene Corp Key News & Latest Developments
7.3 CTI BioPharma Corp
7.3.1 CTI BioPharma Corp Company Summary
7.3.2 CTI BioPharma Corp Business Overview
7.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.3.4 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.3.5 CTI BioPharma Corp Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Company Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.5 Gilead Sciences Inc
7.5.1 Gilead Sciences Inc Company Summary
7.5.2 Gilead Sciences Inc Business Overview
7.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.5.4 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.5.5 Gilead Sciences Inc Key News & Latest Developments
7.6 Incyte Corp
7.6.1 Incyte Corp Company Summary
7.6.2 Incyte Corp Business Overview
7.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.6.4 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.6.5 Incyte Corp Key News & Latest Developments
7.7 Italfarmaco SpA
7.7.1 Italfarmaco SpA Company Summary
7.7.2 Italfarmaco SpA Business Overview
7.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.7.4 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.7.5 Italfarmaco SpA Key News & Latest Developments
7.8 JW Pharmaceutical Corp
7.8.1 JW Pharmaceutical Corp Company Summary
7.8.2 JW Pharmaceutical Corp Business Overview
7.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.8.4 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.8.5 JW Pharmaceutical Corp Key News & Latest Developments
7.9 MedImmune LLC
7.9.1 MedImmune LLC Company Summary
7.9.2 MedImmune LLC Business Overview
7.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.9.4 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.9.5 MedImmune LLC Key News & Latest Developments
7.10 MEI Pharma Inc
7.10.1 MEI Pharma Inc Company Summary
7.10.2 MEI Pharma Inc Business Overview
7.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.10.4 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.10.5 MEI Pharma Inc Key News & Latest Developments
7.11 Merck & Co Inc
7.11.1 Merck & Co Inc Company Summary
7.11.2 Merck & Co Inc Business Overview
7.11.3 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.11.4 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.11.5 Merck & Co Inc Key News & Latest Developments
7.12 Novartis AG
7.12.1 Novartis AG Company Summary
7.12.2 Novartis AG Business Overview
7.12.3 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.12.4 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.12.5 Novartis AG Key News & Latest Developments
7.13 NS Pharma Inc
7.13.1 NS Pharma Inc Company Summary
7.13.2 NS Pharma Inc Business Overview
7.13.3 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.13.4 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.13.5 NS Pharma Inc Key News & Latest Developments
7.14 Promedior Inc
7.14.1 Promedior Inc Company Summary
7.14.2 Promedior Inc Business Overview
7.14.3 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.14.4 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.14.5 Promedior Inc Key News & Latest Developments
7.15 Sun Pharma Advanced Research Company Ltd
7.15.1 Sun Pharma Advanced Research Company Ltd Company Summary
7.15.2 Sun Pharma Advanced Research Company Ltd Business Overview
7.15.3 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Major Product Offerings
7.15.4 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global Market (2018-2023)
7.15.5 Sun Pharma Advanced Research Company Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Opportunities & Trends in Global Market
Table 2. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Drivers in Global Market
Table 3. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Restraints in Global Market
Table 4. Key Players of Post-Polycythemia Vera Myelofibrosis (PPV-MF) in Global Market
Table 5. Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Type
Table 9. List of Global Tier 1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2024-2032
Table 30. AbbVie Inc Company Summary
Table 31. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 32. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Inc Key News & Latest Developments
Table 34. Celgene Corp Company Summary
Table 35. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 36. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Corp Key News & Latest Developments
Table 38. CTI BioPharma Corp Company Summary
Table 39. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 40. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 41. CTI BioPharma Corp Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Ltd Company Summary
Table 43. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 44. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 46. Gilead Sciences Inc Company Summary
Table 47. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 48. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 49. Gilead Sciences Inc Key News & Latest Developments
Table 50. Incyte Corp Company Summary
Table 51. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 52. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 53. Incyte Corp Key News & Latest Developments
Table 54. Italfarmaco SpA Company Summary
Table 55. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 56. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 57. Italfarmaco SpA Key News & Latest Developments
Table 58. JW Pharmaceutical Corp Company Summary
Table 59. JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 60. JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 61. JW Pharmaceutical Corp Key News & Latest Developments
Table 62. MedImmune LLC Company Summary
Table 63. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 64. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 65. MedImmune LLC Key News & Latest Developments
Table 66. MEI Pharma Inc Company Summary
Table 67. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 68. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 69. MEI Pharma Inc Key News & Latest Developments
Table 70. Merck & Co Inc Company Summary
Table 71. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 72. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 73. Merck & Co Inc Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 76. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 77. Novartis AG Key News & Latest Developments
Table 78. NS Pharma Inc Company Summary
Table 79. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 80. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 81. NS Pharma Inc Key News & Latest Developments
Table 82. Promedior Inc Company Summary
Table 83. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 84. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 85. Promedior Inc Key News & Latest Developments
Table 86. Sun Pharma Advanced Research Company Ltd Company Summary
Table 87. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Offerings
Table 88. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (US$, Mn) & (2018-2023)
Table 89. Sun Pharma Advanced Research Company Ltd Key News & Latest Developments
List of Figures
Figure 1. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Type in 2022
Figure 2. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Segment by Application in 2022
Figure 3. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in 2022
Figure 8. By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 9. By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 10. By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 12. By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 14. By Region - Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 15. By Country - North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 16. US Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 20. Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 21. France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 28. China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 32. India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 34. Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share, 2018-2032
Figure 37. Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue, (US$, Mn), 2018-2032
Figure 41. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
